3,539 findings · published 2025+
- CellularStrong
Stage 2 obesity requires excess waist circumference or waist-to-height ratio, along with symptoms or comorbid conditions.
Practitioners should assess waist measurements and related symptoms for obesity classification.
Supports 2025New - Metabolic adaptationStrong
The refined framework aims to enhance precision in identifying obesity and its health risks.
Practitioners can use this framework to better assess obesity-related health risks.
Supports 2025New - Energy balanceStrong
206,361 individuals (68.6%) had obesity according to the new definition compared to 128,992 individuals (42.9%) according to the traditional definition.
Practitioners should consider the new definition of obesity when assessing patients.
Supports 2025New - Energy balanceStrong
108,650 individuals (36.1%) had clinical obesity according to the new definition, with prevalence increasing with age.
Age should be considered when evaluating obesity risk in patients.
Supports 2025New - Metabolic adaptationStrong
Short term dietary trials are highly susceptible to bias due to physiological adaptation to major changes in nutrients.
Practitioners should be aware that results from short-term dietary trials may be influenced by the time it takes for physiological changes to occur.
Supports 2025New - Energy balanceStrong
The article proposes measures to strengthen causal inference in dietary trials.
Implementing proposed measures could enhance the reliability of findings in dietary research.
Supports 2025New - CellularStrong
Most upper airway anatomy was significantly associated with BMI among patients with OSA.
Practitioners should consider the impact of BMI on upper airway anatomy when assessing OSA.
Supports 2025New - CellularStrong
All pharyngeal soft tissues were larger with greater BMI, including the volumes of the tongue, soft palate, and lateral walls.
Increased soft tissue volume with higher BMI should be considered in OSA management.
Supports 2025New - CellularStrong
Understanding novel mutations in POMC and MC4R/MC3R may help identify strategies for the treatment and diagnosis of obesity, particularly childhood obesity.
This knowledge can guide interventions for childhood obesity.
Supports 2025New - Energy balanceStrong
Metabolically healthy individuals experienced lower event rates with increasing body mass index (BMI).
Emphasizing metabolic health may lead to better outcomes even in individuals with higher BMI.
Supports 2025New - CellularStrong
Antidiabetic medications impact skeletal muscle lipid metabolism.
Practitioners should consider the effects of antidiabetic medications on lipid metabolism when treating patients.
Supports 2025New - Metabolic adaptationStrong
Current research has focused more on muscle mass than on skeletal muscle lipid metabolism.
Researchers should shift focus to skeletal muscle lipid metabolism in future studies.
Supports 2025New - MolecularStrong
Adipose tissue browning is linked to improved metabolic and cardiovascular health.
Promoting adipose tissue browning may enhance metabolic and cardiovascular health.
Supports 2025New - CellularStrong
Interventions like ASK-1 knockout, nitrate, and melatonin have increased thermogenesis and improved metabolic outcomes.
Consider these interventions to enhance thermogenesis in metabolic health strategies.
Supports 2025New - MolecularStrong
White adipose tissue browning mitigates inflammation and improves cardiometabolic health.
Encouraging white adipose tissue browning may reduce inflammation and enhance cardiometabolic health.
Supports 2025New - Metabolic adaptationStrong
Nearly half of all patients listed for kidney transplant have obesity, which is associated with increased rates of perioperative complications and graft loss.
Healthcare providers should be aware of the high prevalence of obesity in kidney transplant candidates and its implications for surgery.
Supports 2026New - Energy balanceStrong
Overweight and obesity are significant health challenges addressed globally by the WHO.
Health practitioners should recognize the global significance of overweight and obesity in their practice.
Supports 2026New - Energy balanceStrong
The discussion on appropriate measures for weight reduction is controversial.
Practitioners should be prepared for diverse opinions on weight loss strategies.
Supports 2026New - CellularStrong
Metabolische unerwünschte Arzneimittelwirkungen (mUAW) von Psychopharmaka umfassen Gewichtszunahme, gestörte Glukosetoleranz, Diabetes mellitus und Dyslipidämie.
Healthcare providers should monitor metabolic parameters in patients on psychotropic medications.
Supports 2025New - CellularStrong
Lower body mass index is a significant independent factor for paraspinal muscle atrophy in preoperative lumbar spinal stenosis and lumbar disk herniation patients.
Practitioners should consider body mass index when assessing risk for muscle atrophy in these patients.
Supports 2025New - CellularStrong
Reduced lumbar lordosis angle is a significant independent factor for paraspinal muscle atrophy in preoperative lumbar spinal stenosis and lumbar disk herniation patients.
Practitioners should consider lumbar lordosis angle when assessing risk for muscle atrophy in these patients.
Supports 2025New - MolecularStrong
Modern pharmacotherapies are fundamental to CKD prevention.
Incorporate modern pharmacotherapies into CKD prevention strategies.
Supports 2026New - Energy balanceStrong
79% of studies testing weight loss as a mechanism found no support or found that interventions were less effective/harmful for fatter people.
Practitioners should be cautious about relying on weight loss as a mechanism for DPP effectiveness.
Refutes 2026New - Energy balanceStrong
Participants reported meaningful personal insights from using CGM despite no statistically significant improvements in well-being or health state.
Insights gained from CGM usage can be valuable for athletes, even without measurable health improvements.
Qualifies 2026New